Shlomo A Koyfman1, Jay S Cooper2, Jonathan J Beitler3, Paul M Busse4, Christopher U Jones5, Mark W McDonald6, Harry Quon7, John A Ridge8, Nabil F Saba9, Joseph K Salama10, Farzan Siddiqui11, Richard V Smith12, Francis Worden13, Min Yao14, Sue S Yom15. 1. Cleveland Clinic, Cleveland, Ohio. 2. Maimonides Cancer Center, Brooklyn, New York. 3. Emory University School of Medicine, Atlanta, Georgia. 4. Massachusetts General Hospital, Boston, Massachusetts. 5. Radiologic Associates of Sacramento, Sacramento, California. 6. Indiana University School of Medicine, Indianapolis, Indiana. 7. Johns Hopkins University, Baltimore, Maryland. 8. Fox Chase Cancer Center, Philadelphia, Pennsylvania, American College of Surgeons. 9. Emory University, Atlanta, Georgia, American Society of Clinical Oncology. 10. Duke University, Durham, North Carolina. 11. Henry Ford Health System, Detroit, Michigan. 12. Montefiore Medical Center, Bronx, New York, American College of Surgeons. 13. University of Michigan, Ann Arbor, Michigan, American Society of Clinical Oncology. 14. University Hospitals Case Medical Center, Cleveland, Ohio. 15. University of California San Francisco, San Francisco, California.
Abstract
BACKGROUND: Aggressive nonmelanomatous skin cancer (NMSC) of the head and neck presents an increasingly common therapeutic challenge for which prospective clinical trials are lacking. METHODS: The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 3 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment. RESULTS: The American College of Radiology Expert Panel on Radiation Oncology - Head and Neck Cancer developed consensus recommendations for guiding management of aggressive NMSC. CONCLUSION: Multidisciplinary assessment is vital to guiding the ideal use of surgery, radiation, and systemic therapy in this disease.
BACKGROUND:Aggressive nonmelanomatous skin cancer (NMSC) of the head and neck presents an increasingly common therapeutic challenge for which prospective clinical trials are lacking. METHODS: The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 3 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment. RESULTS: The American College of Radiology Expert Panel on Radiation Oncology - Head and Neck Cancer developed consensus recommendations for guiding management of aggressive NMSC. CONCLUSION: Multidisciplinary assessment is vital to guiding the ideal use of surgery, radiation, and systemic therapy in this disease.
Authors: Samantha Tam; Christopher M K L Yao; Moran Amit; Mona Gajera; Xiaoning Luo; Rachel Treistman; Anshu Khanna; Mohamed Aashiq; Priyadharsini Nagarajan; Diana Bell; Adel El-Naggar; Michael Migden; Michael Wong; Bonnie Glisson; Renata Ferrarotto; Bita Esmaeli; David Rosenthal; Guojun Li; Randal S Weber; Jeffrey N Myers; Neil D Gross Journal: JAMA Otolaryngol Head Neck Surg Date: 2020-02-01 Impact factor: 6.223
Authors: Sofian Benkhaled; Dirk Van Gestel; Carolina Gomes da Silveira Cauduro; Samuel Palumbo; Veronique Del Marmol; Antoine Desmet Journal: Front Med (Lausanne) Date: 2022-06-27